Stock screener

CRL

Conviction 86HealthcareScan · Thu, Jun 25, 2026
CRL$212.64+5.22%
ResistanceSupportVol 14Congress buyCongress sell
63 bars
Vol MA14 988.2K
Mar 26Apr 14May 1May 19Jun 8Jun 25
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCHwww.criver.com ↗
Price212.64
Change+5.22%
Gap+1.16%
Rel volume5.14×
Avg volume960.65K
Avg $ vol183.43M
SMA 20186.38
SMA 50176.04
SMA 200178.68
Price vs 50+20.79%
Price vs 200+19.01%
MA stackmixed
50/200 cross—
Supertrendup · 183.43
RSI (14)72
MACD hist1.97
MACD crossbull · 1d
Stoch %K / %D99 / 89
ADX (14)21
+DI / −DI37 / 14
RSI divergence—
MACD divergence—
ATR %+3.91%
ADR %4.40%
52w high226.77
52w low145.57
From 52w high-6.23%
Above 52w low+46.07%
New 52w highNo
SqueezeOff
Bollinger width17.17%
%B1.32
Donchian pos99.61%
Donchian high212.83
Donchian low163.98
AVWAP (52w high)176.47
vs AVWAP high+20.50%
AVWAP (52w low)177.96
vs AVWAP low+19.49%
OBV trendUp
Chaikin MF (20)0.28
Today vs 20d5.14×
Avg vol (14d)988.2K
Avg vol (20d)960.65K
Avg $ vol (20d)183.43M
Market cap10.24B
RS 3m (vs SPY)+14.70%
RS 6m (vs SPY)-5.18%
RS line new highYes
Trend template7/8
Technical rank80.0
1 week+16.62%
1 month+35.67%
3 months+28.18%
6 months+4.74%
1 year+43.29%
YTD+5.05%
P/E-70.96
P/B3.48
P/S2.55
P/FCF19.75
EPS-2.91
Div yield—
ROE-4.91%
ROA-1.87%
Debt/Eq0.56
Current1.36
EV/EBITDA27.27
Gross margin7.47%
Net margin-3.59%
Rev growth-0.85%
EPS growth-750.08%
Price target208.40
Target upside-1.99%
Analyst ratingBuy
Institutional133.26%
Ent. value11.68B
Revenue995.83M
Net income-14.84M
Gross profit—
Free cash flow518.49M
IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
ExchangeNYSE
Shares out48.17M
Employees19.7K
ListedFri, Jun 23, 2000
Free float48.7M
Float %98.7%
Short interest3.9M
Days to cover3.6d
Short volume69.9%
Squeeze score69 / 100
Next earningsWed, Aug 5, 2026 (41d)
EPS forecast$2.75 · 6 est
Last EPS vs est$2.06 vs $1.96
Last surprise+5.1% beat
Setup gradeA+
Conviction86 / 100
Pattern quality—
Tech rank80.0 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance194.19
Support157.83
Days since event—
Candle confirm—
News sentiment—

Financials as of Sat, Mar 28, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CRL · 5 recent

All disclosures →
MemberSideAmount
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-05-12
Sell$15K–$50K
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-05-08
Buy$15K–$50K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-05-15
Sell$1K–$15K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-04-08
Buy$15K–$50K
Julie Johnson
Julie Johnson
house · D · TX · traded 2025-01-15
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in CRL · 4 buys · 5 sells

InsiderSideShares
FOSTER JAMES C
Director · Common Stock · 2026-06-05
Gift153.36K
FOSTER JAMES C
Director · Common Stock · 2026-06-05
Other—
FOSTER JAMES C
Director · Common Stock · 2026-06-05
Gift153.36K
Girshick Birgit
Chief Executive Officer · Common Stock · 2026-06-05
Gift3.39K
FOSTER JAMES C
Director · Common Stock · 2026-06-05
Gift10K
Girshick Birgit
Chief Executive Officer · Common Stock · 2026-06-05
Gift3.39K
FOSTER JAMES C
Director · Common Stock · 2026-06-05
Gift20K
Parisotto Shannon M
CEVP, Disc & Safety Assessment · Common Stock · 2026-06-05
Gift1.53K
FOSTER JAMES C
Director · Common Stock · 2026-06-05
Gift20K
Parisotto Shannon M
CEVP, Disc & Safety Assessment · Common Stock · 2026-06-05
Gift1.53K

SEC filings

EDGAR filings in CRL

EDGAR →

No recent SEC filings on file for CRL.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.